Risperidone reduces limited access alcohol drinking in alcohol-preferring rats

European Journal of Pharmacology

Volumn 468, Issue 2, 2003, Pages 121-127

  Ingman, Kimmo ^a   Honkanen, Aapo ^a   Hyytiä, Petri ^b   Huttunen, Matti O ^b   Korpi, Esa R ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

(Selected rat line); Alcohol preference; Food consumption; Locomotor activity; Risperidone

Indexed keywords

ALCOHOL; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RISPERIDONE; SACCHARIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DISEASE MODEL; DOSE TIME EFFECT RELATION; DRINKING BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0038057992     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01669-8     Document Type: Article

References (44)

1. Biggs T.A., Myers R.D. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats. Pharmacol. Biochem. Behav. 60:1998;407-413.
2. 2A binding sites in P and in AA alcohol-preferring rats. Brain Res. Bull. 44:1997;33-37.
3. 3 receptors in P and in AA alcohol-preferring rats: an autoradiographic study. Brain Res. Bull. 46:1998;311-315.
4. Eriksson K. Genetic selection for voluntary alcohol consumption in the albino rat. Science. 159:1968;739-741.
5. Grace A.A. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction. 95(Suppl. 2):2000;S119-S128.
6. Gupta S., Black D.W., Smith D.A. Risperidone: review of its pharmacology and therapeutic use in schizophrenia. Ann. Clin. Psychiatry. 6:1994;173-180.
7. 2 receptors. Int. Clin. Psychopharmacol. 10:1995;19-30.
8. Honkanen A., Ahtee L., Korpi E.R. Voluntary alcohol drinking selectively accelerates dopamine release in the ventral striatum as reflected by 3-methoxytyramine levels. Brain Res. 774:1997;207-210.
9. 2 antagonistic properties. J. Pharmacol. Exp. Ther. 244:1988;685-693.
10. Johnson B.A., Ait-Daoud N. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology (Berl.). 149:2000;327-344.
11. Kampov-Polevoy A., Garbutt J.C., Janowsky D. Evidence of preference for a high-concentration sucrose solution in alcoholic men. Am. J. Psychiatry. 154:1997;269-270.
12. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
13. Korpi E.R., Sinclair J.D., Kaheinen P., Viitamaa T., Hellevuo K., Kiianmaa K. Brain regional and adrenal mononamine concentrations and behavioral responses to stress in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. 5:1988;417-425.
14. Korpi E.R., Päivärinta P., Abi-Dargham A., Honkanen A., Laruelle M., Tuominen K., Hilakivi L.A. Binding of serotonergic ligand to brain membranes of alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. 9:1992;369-374.
15. Kranzler H.R., Sandstrom K.A., Van Kirk J. Sweet taste preference as a risk factor for alcohol dependence. Am. J. Psychiatry. 158:2001;813-815.
16. Lankford M.F., Bjork A.K., Myers R.D. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats. Alcohol. 13:1996;399-404.
17. Lin N., Hubbard J.I. The increased ethanol preference in rats induced by choice, darkness, or drugs is reduced by ritanserin. Brain Res. Bull. 33:1994;633-638.
18. 2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. J. Pharmacol. Exp. Ther. 300:2002;882-889.
19. 2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J. Pharmacol. Exp. Ther. 265:1993;498-508.
20. McBride W.J., Li T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit. Rev. Neurobiol. 12:1998;339-369.
21. Meert T.F. Ritanserin and alcohol abuse and dependence. Alcohol Alcohol., Suppl. 2:1994;523-530.
22. Megens A.A., Awouters F.H., Niemegeers C.J. Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol. Psychopharmacology (Berl.). 95:1988;493-496.
23. Murphy J.M., McBride W.J., Lumeng L., Li T.K. Contents of monoamines in forebrain regions of alcohol-preferring (P) and -nonpreferring (NP) lines of rats. Pharmacol. Biochem. Behav. 26:1987;389-392.
24. 2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats. Pharmacol. Biochem. Behav. 45:1993;233-237.
25. 2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats. Pharmacol. Biochem. Behav. 45:1993;741-747.
26. 2A receptor occupancy in schizophrenic patients. Am. J. Psychiatry. 156:1999;869-875.
27. 2A antagonists amperozide and FG 5974. Alcohol., Clin. Exp. Res. 21:1997;1448-1454.
28. 2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats. Pharmacol. Biochem. Behav. 46:1993;853-856.
29. 2 receptor antagonist. Brain Res. Bull. 31:1993;595-599.
30. Schotte A., Janssen P.F., Megens A.A., Leysen J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 631:1993;191-202.
31. Schotte A., Bonaventure P., Janssen P.F., Leysen J.E. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. Jpn. J. Pharmacol. 69:1995;399-412.
32. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., De Loore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl.). 124:1996;57-73.
33. Sellers E.M., Higgins G.A., Sobell M.B. 5-HT and alcohol abuse. Trends Pharmacol. Sci. 13:1992;69-75.
34. Silvestre J.S., O'Neill M.F., Fernández A., Palacios J.M. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat. Eur. J. Pharmacol. 318:1996;257-265.
35. Sinclair J.D., Hyytiä P., Nurmi M. The limited access paradigm: description of one method. Alcohol. 9:1992;441-444.
36. Soyka M., De Vry J. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence. Eur. Neuropsychopharmacol. 10:2000;325-332.
37. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22:1999;521-527.
38. van Beijsterveldt L.E., Geerts R.J., Leysen J.E., Megens A.A., Van den Eynde H.M., Meuldermans W.E., Heykants J.J. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat. Psychopharmacology (Berl.). 114:1994;53-62.
39. Wegelius K., Honkanen A., Korpi E.R. Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats. Eur. J. Pharmacol. 263:1994;141-147.
40. Vekovischeva O.Y., Zamanillo D., Echenko O., Seppälä T., Uusi-Oukari M., Honkanen A., Seeburg P.H., Sprengel R., Korpi E.R. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J. Neurosci. 21:2001;4451-4459.
41. Wilson A.W., Neill J.C., Costall B. An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat. Alcohol. 16:1998;249-270.
42. Virkkunen M., Linnoila M. Serotonin in early onset, male alcoholics with violent behaviour. Ann. Med. 22:1990;327-331.
43. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35:1987;227-263.
44. 2 receptor occupancy. Synapse. 46:2002;32-37.